跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
protein combination
首页
药物
protein combination
protein combination
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A
US 8945577 B2
申请人: BLAIS NORMAND
优先权: 2011
CN
US
13 件公开
Topical formulations comprising montelukast and combinations with mussel adhesive proteins
US 11672792 B2
申请人: ENLITISA SHANGHAI PHARMACEUTICAL CO LTD
优先权: 2017
CN
EP
US
WO
5 件公开
COMBINATION OF BISPECIFIC FUSION PROTEIN AND ANTI-HER2 ANTIBODY FOR TUMOR TREATMENT
EP 4069747 A4
申请人: JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD
优先权: 2019
CN
EP
US
WO
5 件公开
COMBINATION THERAPY COMPRISING SIRP ALPHA FUSION PROTEIN AND ANTI-CD19 ANTIBODY FOR TREATMENT OF CANCER
EP 4536708 A4
申请人: INCYTE CORP
优先权: 2022
CN
EP
US
WO
4 件公开
Means and Methods for Increased Protein Expression by Use of a Combination of Transport Proteins and Either Chaperones or Transcription Factors
US 20260209783 A1
申请人: BOEHRINGER INGELHEIM RCV GMBH
优先权: 2022
CN
EP
US
WO
4 件公开
RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION
CN 105255881 A
申请人: ETHRIS GMBH
优先权: 2009
CN
EP
US
4 件公开
Combination of TIS sequence and signal peptide sequence for expressing a recombinant protein
US 12584143 B2
申请人: XBRANE BIOPHARMA AB
优先权: 2020
EP
US
WO
4 件公开
Combination therapy for treating protein deficiency disorders
US 2007178081 A1
申请人: FAN JIAN-QIANG
优先权: 2003
CN
US
4 件公开
Combination of drugs with protein-binding prodrugs
US 10220101 B2
申请人: KRATZ FELIX
优先权: 2010
EP
US
4 件公开
Combination treatment for cancer with anti-BCMA binding protein and proteosome inhibitor
US 11401334 B2
申请人: GLAXOSMITHKLINE IP DEV LTD
优先权: 2017
CN
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈